Want to see TVRD full AI Analyst Report?
Tvardi Therapeutics (TVRD) Stock Forecast & Price Target
TVRD Analyst Ratings
TVRD Stock 12 Month Forecast
Average Price Target
$8.17▲(845.22% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Debanjana Chatterjee | JonesTrading | $10 | buy | 1057.41%Upside | Reiterated | 11/03/26 | ||
| Gautam Chukka | Chardan Capital | $8 | buy | 825.93%Upside | Initiated | 10/20/26 | ||
| Elemer Piros | Lucid Capital | $6→$14 | buy | 1520.37%Upside | Initiated | 09/08/26 | ||
| Sara Nik | H.C. Wainwright | $9 | buy | 941.67%Upside | Reiterated | 08/21/26 | ||
| Etzer Darout | Barclays | $3 | sell | 247.22%Upside | Reiterated | 08/20/26 | ||
| Julian Harrison | BTIG | $5 | buy | 478.70%Upside | Reiterated | 08/19/26 | ||
 Unknown AnalystNot Ranked | Cantor Fitzgerald | ― | hold | ― | Reiterated | 08/19/26 | ||
| Ryan Deschner | Raymond James | $10 | buy | 1057.41%Upside | Upgraded | 07/08/26 | ||
| Yasmeen Rahimi | Piper Sandler | $13 | buy | 1404.63%Upside | Upgraded | 07/08/26 | ||
| Jay Olson | Oppenheimer | $10 | buy | 1057.41%Upside | Reiterated | 05/11/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Debanjana ChatterjeeJonesTrading | BuyReiterated$10 | 11/03/26 | 1057.41%Upside | ||
| Gautam ChukkaChardan Capital | BuyInitiated$8 | 10/20/26 | 825.93%Upside | ||
| Elemer PirosLucid Capital | BuyInitiated$6→$14 | 09/08/26 | 1520.37%Upside | ||
| Sara NikH.C. Wainwright | BuyReiterated$9 | 08/21/26 | 941.67%Upside | ||
| Etzer DaroutBarclays | SellReiterated$3 | 08/20/26 | 247.22%Upside | ||
| Julian HarrisonBTIG | BuyReiterated$5 | 08/19/26 | 478.70%Upside | ||
| Unknown AnalystCantor FitzgeraldNot Ranked | HoldReiterated | 08/19/26 | ― | ||
| Ryan DeschnerRaymond James | BuyUpgraded$10 | 07/08/26 | 1057.41%Upside | ||
| Yasmeen RahimiPiper Sandler | BuyUpgraded$13 | 07/08/26 | 1404.63%Upside | ||
| Jay OlsonOppenheimer | BuyReiterated$10 | 05/11/26 | 1057.41%Upside |
Best Analysts Covering Tvardi Therapeutics
Copying Debanjana Chatterjee's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of -20.10% per trade.
Copying Julian Harrison's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -75.71% per trade.
Copying Julian Harrison's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -77.84% per trade.
TVRD Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 9 | 11 | 12 | 8 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 |
| Sell | 3 | 5 | 5 | 3 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 13 | 17 | 18 | 12 | 4 |
In the current month, TVRD has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TVRD average Analyst price target in the past 3 months is 8.17.
TVRD Financial Forecast
TVRD Earnings Forecast
Next quarter’s earnings estimate for TVRD is -$0.57 with a range of -$1.06 to -$0.28. The previous quarter’s EPS was -$0.69. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
TVRD Sales Forecast
Next quarter’s sales forecast for TVRD is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
